Is Localized Provoked Vulvodynia Caused by Laxity of the Utero-Sacral Ligaments?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-23

Study Completion Date

2018-03-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Small-scale experiments conducted by our group have led to the hypothesis that Localized Provoked Vulvodynia (LPV) may be due to laxity of the Utero-Sacral ligaments (USL). According to this hypothesis, the pain experienced by women with LPV is due to the USL's inability to provide appropriate support for the pudendal nerve.

In order to test this hypothesis we will conduct a single-blind randomized control trial in which patients with LPV will undergo a pressure-test - pressure will be temporarily applied to the posterior fornix using a large-sized applicator, thus strengthening the USL and adding support to the pudendal nerve. While the pressure is being applied, the cotton-swab test will be performed (palpating vulvar and vestibular sites using a cotton-swab), and each patient will rate the elicited pain on a scale of 1 to 10 (1 - not painful, 10 - worst pain imaginable).

The results for each patient will be compared to their baseline level of pain (which will be recorded in the beginning of the experiment) and to the level of pain they report while inserting a speculum but not applying any pressure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Reciprocal Relations Between Psychosocial Characteristics and the Progression of Vestibulodynia

NCT02892214

Localized Provoked Vulvodynia

COMPLETED

Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions Before the Delivery

NCT03883867

Pelvic Floor Perineal Rupture Obstetric Trauma

COMPLETED

Subtypes of Provoked Vestibulodynia

NCT02712814

Provoked Localized Vulvodynia

COMPLETED

Location and Anatomic Characterization of the Sacrospinous Ligaments in Women With Pelvic Organ Prolapse

NCT01852422

Pelvic Organ Prolapse

COMPLETED

Manual Fascial Manipulation in Pregnant Women

NCT03041246

Pelvic Floor Disorders

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with LPV who sign an informed consent form will first undergo the cotton-swab test during which they will rate the pain elicited on a scale of 1 to 10. This score will be used as the patient's baseline level of pain for data analysis later. Then, each patient will be randomized into one of two groups: One group which will first undergo the control manipulation and then the study manipulation, or the second group in which the study manipulation will precede the control manipulation. This is done to neutralize a possible effect of the order of the manipulations on the trial's results when the data will be analyzed.

The control manipulation: Inserting a speculum into the vagina without applying pressure.

The study manipulation: First inserting a speculum, then inserting through it a large-sized applicator reaching the posterior fornix, then retrieving the speculum while keeping the applicator in place, and then applying significant pressure to the posterior fornix.

During each of the manipulations, the cotton-swab test will be performed again, and each patient will be asked to rate the level of pain elicited by the test. All data will be recorded, and we will later analyze if there was a significant difference between the pain elicited by the cotton-swab test during the study manipulation compared with the control manipulation, or compared with the baseline test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vulvodynia Referred Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

The participants will not be informed prior to the experiment if they will first undergo the control manipulation or the study manipulation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control manipulation first

Patients in this group will first undergo the control manipulation while the study manipulation will follow.

Group Type EXPERIMENTAL

Pressure-test

Intervention Type PROCEDURE

Pressure will be applied to the posterior fornix using a speculum.

Study manipulation First

Patients in this group will first undergo the study manipulation while the control manipulation will follow.

Group Type EXPERIMENTAL

Pressure-test

Intervention Type PROCEDURE

Pressure will be applied to the posterior fornix using a speculum.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pressure-test

Pressure will be applied to the posterior fornix using a speculum.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who suffer from LPV that are otherwise healthy.
* Symptoms severity in each patient is either moderate (able to engage in sexual intercourse despite suffering immense pain) or severe (unable to engage in sexual intercourse due to unbearable pain).
* Patients who have signed an informed consent form.

Exclusion Criteria

* Women who suffer from Generalized Vulvodynia.
* Women who previously received other treatments for LPV, including but not limited to surgery, neuropathic treatment and/or physiotherapy.
* Women with uterine prolapse.
* Women who present with genito-urinary infection/inflammation at the day of the trial, or have healed from such a condition less then 14 days prior to the day of the trial.
* Women who have previously participated in clinical trials under which they received treatment for Vulvodynia.
* Women with LPV whose symptoms severity is defined as light (able to engage in sexual intercourse while suffering light pain / discomfort).
* Women who are pregnant at the day of the trial.

Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No